ATE31418T1 - Arzneimittel, welche tripeptide enthalten. - Google Patents
Arzneimittel, welche tripeptide enthalten.Info
- Publication number
- ATE31418T1 ATE31418T1 AT85401646T AT85401646T ATE31418T1 AT E31418 T1 ATE31418 T1 AT E31418T1 AT 85401646 T AT85401646 T AT 85401646T AT 85401646 T AT85401646 T AT 85401646T AT E31418 T1 ATE31418 T1 AT E31418T1
- Authority
- AT
- Austria
- Prior art keywords
- medications containing
- containing tripeptides
- tripeptides
- medications
- immunostimulants
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 229960001438 immunostimulant agent Drugs 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8412853A FR2569111B1 (fr) | 1984-08-16 | 1984-08-16 | Nouveaux medicaments contenant des tripeptides |
| EP85401646A EP0174245B1 (de) | 1984-08-16 | 1985-08-14 | Arzneimittel, welche Tripeptide enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE31418T1 true ATE31418T1 (de) | 1988-01-15 |
Family
ID=9307062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85401646T ATE31418T1 (de) | 1984-08-16 | 1985-08-14 | Arzneimittel, welche tripeptide enthalten. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4716151A (de) |
| EP (1) | EP0174245B1 (de) |
| JP (1) | JPS61112097A (de) |
| AT (1) | ATE31418T1 (de) |
| CA (1) | CA1253072A (de) |
| DE (1) | DE3561201D1 (de) |
| FR (1) | FR2569111B1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2565985B1 (fr) * | 1984-06-19 | 1987-09-25 | Rhone Poulenc Sante | Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent |
| US4874608A (en) * | 1987-04-27 | 1989-10-17 | Imreg, Inc. | Therapeutic method for treating malignancies |
| IT1222437B (it) * | 1987-08-04 | 1990-09-05 | Ellem Ind Farmaceutica | Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione |
| DK53291D0 (da) * | 1991-03-25 | 1991-03-25 | Carlbiotech Ltd As | Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser |
| ATE167195T1 (de) * | 1993-03-22 | 1998-06-15 | Leonida Grippa | Monoessigsäure derivate der peptide leu-phe-ala und ala-leu-phe und deren verwendung in der erkennung und vernichtung von tumorzellen und virusinfizierten zellen |
| CA2296311A1 (en) * | 1999-01-28 | 2000-07-28 | Universite Laval | Enzymatic hydrolysate of milk proteins |
| WO2004092206A1 (ja) * | 2003-04-14 | 2004-10-28 | Meiji Dairies Corporation | 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法 |
| WO2010028674A1 (en) * | 2008-09-09 | 2010-03-18 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1497536A (fr) * | 1965-07-02 | 1967-10-13 | Merck & Co Inc | Procédé progressif de synthèse réglée de polypeptides |
| US3435046A (en) * | 1965-07-02 | 1969-03-25 | Merck & Co Inc | Trialkyl-silyl ethers of n-carboxy anhydrides of monohydroxy alpha-amino acids and processes for preparing them |
| JPS5443076B2 (de) * | 1974-04-24 | 1979-12-18 |
-
1984
- 1984-08-16 FR FR8412853A patent/FR2569111B1/fr not_active Expired
-
1985
- 1985-08-14 AT AT85401646T patent/ATE31418T1/de not_active IP Right Cessation
- 1985-08-14 DE DE8585401646T patent/DE3561201D1/de not_active Expired
- 1985-08-14 US US06/765,536 patent/US4716151A/en not_active Expired - Fee Related
- 1985-08-14 EP EP85401646A patent/EP0174245B1/de not_active Expired
- 1985-08-15 JP JP60178692A patent/JPS61112097A/ja active Pending
- 1985-08-15 CA CA000488752A patent/CA1253072A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3561201D1 (en) | 1988-01-28 |
| EP0174245A1 (de) | 1986-03-12 |
| JPS61112097A (ja) | 1986-05-30 |
| US4716151A (en) | 1987-12-29 |
| FR2569111A1 (fr) | 1986-02-21 |
| FR2569111B1 (fr) | 1987-04-17 |
| EP0174245B1 (de) | 1987-12-16 |
| CA1253072A (fr) | 1989-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT54213A (en) | Process for the enzymatic removal of n-terminal sequence of proteins | |
| FI895382A0 (fi) | Uretan-skyddade aminosyra-n -karboxianhydrider. | |
| DE68926248D1 (de) | p100 "neu" menschlisches Protein and Verwendung dieses Proteins zum Nachweis von preneoplasmatischen- oder neoplasmatischen beim Menschen | |
| MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
| AU2672900A (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
| ES551821A0 (es) | Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina. | |
| BG102362A (en) | New derivatives of amino acids, their preparation and application | |
| ATE31418T1 (de) | Arzneimittel, welche tripeptide enthalten. | |
| OA08010A (fr) | The synthesis of cyclopropane amino acids and peptides. | |
| DE3866045D1 (de) | Arzneimittel zur behandlung von uraemie. | |
| IT8319160A0 (it) | Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi. | |
| ATE5314T1 (de) | Pharmakologisch aktive peptide und deren zusammensetzungen. | |
| DK482185D0 (da) | Peptider, deres fremstilling og anvendelse som laegemidler | |
| MX167236B (es) | Peptidos sinteticos de timosina -1 y metodo para su obtencion | |
| DE69431637D1 (de) | Verfahren zur Supplementierung von Aminosäuren an Wiederkäuern | |
| DE3769910D1 (de) | Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung. | |
| ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
| ATE133960T1 (de) | Peptide mit bradykinin-antagonistischer wirkung | |
| CA2259640A1 (en) | Human glycine transporter | |
| ATE163939T1 (de) | Peptide und antikörper zur behandlung von rheumatoider arthritis. | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| ATE92078T1 (de) | Pharmakologisch aktive peptide. | |
| BG102937A (en) | Zona pelucida proteins as contraceptives | |
| ES2114004T3 (es) | Procedimiento de preparacion de peptidos con un residuo prolina amidado en la posicion c-terminal. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |